About Clinipath
Clinipath is a company based in Kuala Lumpur (Malaysia) founded in 1992.. Clinipath has raised $1.8 million across 1 funding round from investors including VentureTECH. Clinipath offers products and services including Laboratory Tests, Molecular Diagnostic Test, Histopathology Services, Haematology Tests, and Cytology Services. Clinipath operates in a competitive market with competitors including Quantum Diagnostics, among others.
- Headquarter Kuala Lumpur, Malaysia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Clinipath (Malaysia) Sdn Bhd
-
Annual Revenue
$6.6 M (USD)-66as on Dec 31, 2022
-
Net Profit
$1.64 M (USD)-64as on Dec 31, 2022
-
EBITDA
$1.44 M (USD)-77as on Dec 31, 2022
-
Total Equity Funding
$1.8 M (USD)
in 1 rounds
-
Latest Funding Round
$1.8 M (USD), Series A
Mar 21, 2018
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clinipath
Clinipath offers a comprehensive portfolio of products and services, including Laboratory Tests, Molecular Diagnostic Test, Histopathology Services, Haematology Tests, and Cytology Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides tests in immunology, microbiology, and biochemistry for medical diagnosis.
Offers rapid genetic testing for disease detection and monitoring.
Conducts tissue analysis for accurate disease identification.
Performs blood tests to evaluate patient health conditions.
Analyzes cells for early detection of abnormalities.
Unlock access to complete
Unlock access to complete
Funding Insights of Clinipath
Clinipath has successfully raised a total of $1.8M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.8 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $1.8M
-
First Round
First Round
(21 Mar 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2018 | Amount | Series A - Clinipath | Valuation | VentureTECH |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Clinipath
Clinipath has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include VentureTECH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VentureTECH is engaged in venture capital investment activities.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Clinipath
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Clinipath
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Clinipath Comparisons
Competitors of Clinipath
Clinipath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quantum Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pathology lab services are operated through a regional chain.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Clinipath
When was Clinipath founded?
Clinipath was founded in 1992 and raised its 1st funding round 26 years after it was founded.
Where is Clinipath located?
Clinipath is headquartered in Kuala Lumpur, Malaysia.
Is Clinipath a funded company?
Clinipath is a funded company, having raised a total of $1.8M across 1 funding round to date. The company's 1st funding round was a Series A of $1.8M, raised on Mar 21, 2018.
What is the annual revenue of Clinipath?
Annual revenue of Clinipath is $6.6M as on Dec 31, 2022.
What does Clinipath do?
Clinipath was established in 1992 in Kuala Lumpur, Malaysia, within the healthcare sector. A network of pathology laboratories is operated to support diagnostic testing and medical analysis. Core services include clinical pathology examinations for patients and healthcare providers across the region. Operations focus on reliable lab workflows in urban and surrounding areas, serving local medical demands without international expansion noted.
Who are the top competitors of Clinipath?
Clinipath's top competitors include Quantum Diagnostics.
What products or services does Clinipath offer?
Clinipath offers Laboratory Tests, Molecular Diagnostic Test, Histopathology Services, Haematology Tests, and Cytology Services.
Who are Clinipath's investors?
Clinipath has 1 investor. Key investors include VentureTECH.